Should a patient with low bone density in the forearm and a T-score below -2.5 be treated with antiresorptive therapy?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Patients with a T-score below -2.5 are usually considered for antiresorptive therapy due to their increased risk for fractures, with treatments like bisphosphonates or denosumab being common options. Comprehensive risk assessments are essential to inform individual treatment decisions.

Fields of Study & Subjects

Bone health and osteoporosis research Bone health and treatments Menopause: Health Impacts and Treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN